American Century Companies’s Array Biopharma Inc ARRY Stock Holding History

American Century Companies’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-276,170	Closed	-$12.8M	–	1397
2019 Q2	$12.8M	Sell	276,170 -1,897,446	-87%	-$53.3M	0.01%	582
2019 Q1	$53M	Sell	2,173,616 -718,295	-25%	-$15M	0.05%	347
2018 Q4	$41.2M	Sell	2,891,911 -224,975	-7%	-$3.41M	0.05%	364
2018 Q3	$47.4M	Buy	3,116,886 +506,146	+19%	+$7.76M	0.05%	357
2018 Q2	$43.8M	Buy	2,610,740 +1,022,370	+64%	+$16.3M	0.04%	375
2018 Q1	$25.9M	Buy	+1,588,370	New	+$25.4M	0.03%	473
2015 Q4	–	Sell	-311,468	Closed	-$1.42M	–	1425
2015 Q3	$1.42M	Buy	311,468 +185,408	+147%	+$1.1M	﹤0.01%	1063
2015 Q2	$909K	Buy	+126,060	New	+$930K	﹤0.01%	1159

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

American Century Companies's ARRY Position: Q3 2019 in Review

American Century Companies sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 276,170 shares — an estimated $12.8M sold.

American Century Companies first reported a position in ARRY in Q2 2015 and held it in 8 quarters. The position peaked at $53M in Q1 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

American Century Companies reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
American Century Companies sold 276,170 Array Biopharma Inc shares in Q3 2019, an estimated $12.8M.
American Century Companies first reported a position in Array Biopharma Inc in Q2 2015 and held it in 8 quarters.
American Century Companies's Array Biopharma Inc position peaked at $53M in Q1 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on American Century Companies's 13F filing for Q3 2019, filed 13 Nov 2019.